AMA study: Pharmacy benefit manager market highly concentrated, integrated with insurers

Oct 13, 2022 - 09:33 PM
Prescription Drug Pricing. Green and white capsules on a pharmacy counter.

The market for pharmacy benefit manager services is highly concentrated, with commercial insurers often sharing ownership in the PBM, according to an analysis released today by the American Medical Association. Based on 2020 data from the commercial insurance market, the study found the 10 largest PBMs share 97% of the market for the three PBM services most used by insurers: negotiating rebates with drug makers, assembling retail pharmacy networks, and administering and processing pharmacy claims.
 
“The American Medical Association already has serious concerns about PBM business practices that can have a detrimental impact on patients’ access to and cost of prescription drugs,” said AMA President Jack Resneck Jr, M.D. “PBM markets require careful scrutiny as less competition and more vertical integration can embolden anti-competitive business practices to the detriment of patients.”
 
AHA has urged the Federal Trade Commission to scrutinize commercial health plans that steer patients to third-party specialty pharmacies in which they have a financial interest, preventing health care providers from procuring and managing the drugs they administer to patients.

Related News Articles

Headline
Administration reaches deal with AstraZeneca on lowering drug costs
The White House Oct. 10 announced it reached an agreement with AstraZeneca to align drug prices with the lowest paid by other developed nations, also known as…
Perspective
Holding Commercial Health Insurers Accountable
Public
“Trust but verify” is a phrase often associated with President Reagan and the need to ensure that treaties enacted with the Soviet Union were being upheld.…
Headline
Administration announces agreement with Pfizer to lower drug costs
President Trump today announced the first agreement with a major pharmaceutical company, Pfizer, to bring American drug prices in line with the lowest paid by…
Headline
FDA discloses warning letters for dozens of drug companies
The Food and Drug Administration recently disclosed dozens of warning letters sent to drug companies that accuse them of using misleading or deceptive…
Headline
Trump directs HHS, FDA to require full safety warnings in drug ads
President Trump Sept. 10 signed a memorandum directing the Department of Health and Human Services and Food and Drug Administration to require drug companies…
Headline
FDA announces new program to boost domestic drug manufacturing 
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…